Physician

Ali Aboufares, MD

According to 2025 Medicare claims, Ali Aboufares, MD (NPI: 1508837287) practices interventional cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bronx, NY. This provider's primary affiliated billing organization is OMNI MEDICAL OF NY, PC (NPI: 1487023768; TIN: 475052804) and primary practice location at 10465-2038. Aboufares is affiliated with the Pearl Primary Care Network, LLC (ACO ID: D0242) and Pearl Network, LLC (ACO ID: D0243), participating under the REACH model.

Aboufares' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 1,875 HCPCS/CPT codes, and received $832,998 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 1,249 prescription claims across 312 beneficiaries totaling $242,012 in drug costs, led by Entresto (Sacubitril/Valsartan). 2021 DME data shows 28 claims. Open Payments data shows 44 records totaling $21,735. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $167,722 and ending at $832,998. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $182,320 to $242,012. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $843 to $18,845.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	333	1,448	$167,722
2016	462	2,177	$779,418
2017	530	1,669	$775,979
2018	488	1,605	$543,806
2019	373	1,952	$1,083,596
2020	238	1,228	$362,137
2021	327	1,702	$545,346
2022	523	2,648	$557,633
2023	564	2,843	$1,422,287
2024	436	1,875	$832,998

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	205	2,701	$182,320
2016	211	2,495	$185,316
2017	200	1,767	$155,492
2018	226	2,006	$180,216
2019	264	1,897	$174,821
2020	278	1,872	$176,182
2021	354	2,349	$288,569
2022	427	2,407	$382,223
2023	463	2,678	$451,271
2024	312	1,249	$242,012

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	19	$256
2016	N/R	21	$268
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	28	28	$18,620
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	129	139	$167
93970	Ultrasound study of arm or leg veins with compression and maneuvers	120	131	$165
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	93	93	$139
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	231	409	$107
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	59	66	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	73	4,207	$87,542
Eliquis	Apixaban	47	2,595	$47,136
Farxiga	Dapagliflozin Propanediol	23	1,230	$22,702
Xarelto	Rivaroxaban	30	1,140	$20,317
Praluent Pen	Alirocumab	11	532	$9,359

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$21,735	AngioDynamics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Aboufares, MD?

Tedicare shows public-source Medicare data for Ali Aboufares, MD (NPI 1508837287), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Aboufares, MD have ACO affiliation data?

Ali Aboufares, MD is shown with ACO affiliation data for Pearl Primary Care Network, LLC (REACH, ACO ID D0242) and Pearl Network, LLC (REACH, ACO ID D0243).

What billing organization is linked to Ali Aboufares, MD?

Ali Aboufares, MD is linked to OMNI MEDICAL OF NY, PC (billing NPI 1487023768) in the available physician profile data.

Does Ali Aboufares, MD have Open Payments data?

Ali Aboufares, MD has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.